ConvaTec Group PLC
LSE:CTEC

Watchlist Manager
ConvaTec Group PLC Logo
ConvaTec Group PLC
LSE:CTEC
Watchlist
Price: 222 GBX 0.45% Market Closed
Market Cap: 4.6B GBX
Have any thoughts about
ConvaTec Group PLC?
Write Note

ConvaTec Group PLC
Income from Continuing Operations

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

ConvaTec Group PLC
Income from Continuing Operations Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Income from Continuing Operations CAGR 3Y CAGR 5Y CAGR 10Y
ConvaTec Group PLC
LSE:CTEC
Income from Continuing Operations
$130.3m
CAGR 3-Years
5%
CAGR 5-Years
-7%
CAGR 10-Years
N/A
Abingdon Health PLC
LSE:ABDX
Income from Continuing Operations
-ÂŁ3.5m
CAGR 3-Years
-1%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Tristel PLC
LSE:TSTL
Income from Continuing Operations
ÂŁ6m
CAGR 3-Years
10%
CAGR 5-Years
12%
CAGR 10-Years
18%
Inspecs Group PLC
LSE:SPEC
Income from Continuing Operations
-ÂŁ997k
CAGR 3-Years
52%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Advanced Medical Solutions Group PLC
LSE:AMS
Income from Continuing Operations
ÂŁ11.1m
CAGR 3-Years
-7%
CAGR 5-Years
-12%
CAGR 10-Years
-1%
Rua Life Sciences PLC
LSE:RUA
Income from Continuing Operations
-ÂŁ1.4m
CAGR 3-Years
0%
CAGR 5-Years
-19%
CAGR 10-Years
N/A
No Stocks Found

ConvaTec Group PLC
Glance View

Market Cap
4.6B GBX
Industry
Health Care

ConvaTec Group PLC is a notable player in the realm of medical products and technologies, deftly weaving its narrative within the healthcare industry. Founded in 1978, the company has steadily established itself through strategic expansion and innovation, focusing on improving the lives of patients and enhancing healthcare delivery. The company's core business revolves around four main product categories: Advanced Wound Care, Ostomy Care, Continence and Critical Care, and Infusion Care. Each of these sectors is backed by a robust commitment to research and development, allowing ConvaTec to deliver specialized products that cater to both specific patient needs and broader healthcare system demands. ConvaTec's financial model centers around providing essential, high-quality medical solutions that ultimately support improved patient outcomes. The company garners revenue by partnering with hospitals, healthcare providers, and direct consumer channels, ensuring its products reach where they are most needed. With a global footprint spanning multiple continents, ConvaTec not only distributes its products widely but also adapts its strategy to meet the nuanced requirements of diverse markets. By aligning itself closely with caregivers and leveraging cutting-edge technology, the company maintains a sustainable economic engine through both recurring sales from consumables and long-term relationships with its institutional clients.

CTEC Intrinsic Value
286.3 GBX
Undervaluation 22%
Intrinsic Value
Price

See Also

What is ConvaTec Group PLC's Income from Continuing Operations?
Income from Continuing Operations
130.3m USD

Based on the financial report for Dec 31, 2023, ConvaTec Group PLC's Income from Continuing Operations amounts to 130.3m USD.

What is ConvaTec Group PLC's Income from Continuing Operations growth rate?
Income from Continuing Operations CAGR 5Y
-7%

Over the last year, the Income from Continuing Operations growth was 107%. The average annual Income from Continuing Operations growth rates for ConvaTec Group PLC have been 5% over the past three years , -7% over the past five years .

Back to Top